The Doctor’s Advocate | Third Quarter 2012
Approximately 500,000 adverse drug events (ADEs) are reported annually to the U.S. Food and Drug Administration (FDA)—according to FDA data, this number is growing rapidly.
However, published studies indicate that as few as one in 10 ADEs are actually reported by health care professionals, largely due to the time-consuming and inefficient processes involved.
RxEvent, a HIPAA-compliant service available to all U.S. health care professionals, provides quick, convenient online access for reporting ADEs.
Designed by PDR Network and its partners to improve reporting convenience, RxEvent is an online network that collects information on adverse drug events and distributes it to the manufacturer and/or the FDA.
If you have encountered an ADE, please report it to RxEvent at www.rxevent.org/Partner/00001.
The Doctor’s Advocate is published by The Doctors Company to advise and inform its members about loss prevention and insurance issues.
The guidelines suggested in this newsletter are not rules, do not constitute legal advice, and do not ensure a successful outcome. They attempt to define principles of practice for providing appropriate care. The principles are not inclusive of all proper methods of care nor exclusive of other methods reasonably directed at obtaining the same results.
The ultimate decision regarding the appropriateness of any treatment must be made by each healthcare provider in light of all circumstances prevailing in the individual situation and in accordance with the laws of the jurisdiction in which the care is rendered.
The Doctor’s Advocate is published quarterly by Corporate Communications, The Doctors Company. Letters and articles, to be edited and published at the editor’s discretion, are welcome. The views expressed are those of the letter writer and do not necessarily reflect the opinion or official policy of The Doctors Company. Please sign your letters, and address them to the editor.
Third Quarter 2012
A Diagnostic Blind Spot
An Ounce of Prevention
Delay in Treatment of Fetal Distress
Procedural Trick Presents Advocacy Challenge
The Back Page
Industry and Company News